[Endonasal electrophoresis of dalargin in the therapy of multiple and giant duodenal ulcers].
D000281:Administration, Intranasal; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004381:Duodenal Ulcer / Q000188:drug therapy*; D016308:Enkephalin, Leucine-2-Alanine / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D007478:Iontophoresis / Q000295:instrumentation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D016896:Treatment Outcome
D000897:Anti-Ulcer Agents; D004364:Pharmaceutical Preparations; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Endonazal'nyĭ élektroforez dalargina v terapii mnozhestvennykh i gigantskikh iazv dvenadtstiperstnoĭ kishki.